Update on Fiasp insulin 17 August 2023 Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. We have been advised that negotiations are continuing. Both the Government and the manufacturer have been made aware of the significant angst this is causing the diabetes community Diabetes Australia will continue to advocate on this issue. We have set up a page – Fight for Fiasp – where you can lend your voice and advocate on this issue. We will keep you updated, as and when we hear anything on this issue.
Media releases 6 November 2026 Diabetes Australia welcomes new oral GLP-1 treatment option for Australians Diabetes Australia welcomes the Therapeutic Goods Administration’s (TGA) recent approval of a new oral formulation of Wegovy (semaglutide) as a step forward in the treatment of obesity and related chronic conditions. Continue Reading
Blog 1 November 2026 Sex, periods and hormones with type 1 diabetes In this episode of the Life on the Level podcast, co-host Isabella Magee and credentialled diabetes educator Cheryl Nankivell talk about positive ways you can protect your health while living the life you want. Continue Reading
Blog 5 October 2026 Isabella Magee: Changing the conversation around type 1 diabetes Meet Isabella Magee, turning years of struggle with type 1 diabetes into a commitment to education and advocacy on the Life on the Level podcast. Continue Reading